September 21, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Toray to Acquire Equity Stake in Mitsui Subsidiary MicroBiopharm
 

Tokyo, Jan 5, 2012 (JCN) - Toray Industries Inc. will be acquiring a 20% stake in Mitsui & Co. Ltd's wholly-owned subsidiary MicroBiopharm Japan Co. Ltd (MJB).

MBJ is involved in the manufacture, including contract manufacturing, and sale of pharmaceuticals (API, intermediates) produced using proprietary production technology created by combining biotechnology with fermentation technology developed over many years. It also uses this technology to produce and sell fine specialty chemicals. In addition, MBJ manufactures and sells pharmaceuticals, especially anticancer drugs, through its Chinese affiliate Shenzhen Main Luck Pharmaceuticals Inc., in which it has a 34% shareholding.

Toray sees this investment as an opportunity to expand its technology sharing with MBJ, discover new drugs and strengthen its manufacturing infrastructure. It will also provide new impetus for the expansion of MBJ's product categories. Mitsui aims to use its global network and business experience in the medical and healthcare field and chemicals segment to help MBJ products achieve a larger share in the world market. Both Toray and Mitsui intend to use their experience and know-how to enhance the potential of MBJ while also strengthening their relationship in the medical and healthcare field and chemicals segment through their collaboration with MBJ.

By Chris Lui Staff Writer

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Toray News  
  Toray Expands Automobile-related Carbon Fiber Composite Material Business in U.S.  (July 18, 2013)
  Toray and Gevo Sign Bio-Paraxylene Offtake Agreement for Bio-based PET Production  (June 28, 2012)
  Ajinomoto and Toray to Collaborate on Biobased Nylon Research  (Feb 20, 2012)
  Toray to Supply RO Membrane to Asia's Largest Desalination Plant  (Feb 10, 2012)
  Toray to Build New Artificial Kidney Plant in China  (Feb 3, 2012)
  Toray Acquires Remaining Shares in French Carbon Fiber Manufacturing Venture  (Jan 20, 2012)
  Toray to Acquire Equity Stake in Mitsui Subsidiary MicroBiopharm  (Jan 5, 2012)
  Toray, Japan Tobacco and Torii Terminate the Joint Development of Nalfurafine Hydrochloride for Pruritus  (Dec 27, 2011)
  Toray Produces World's First Fully Renewable, Biobased Polyethylene Terephthalate (PET) Fiber  (Nov 24, 2011)
  Toray, Mitsubishi Tanabe Pharma Sign Agreement on TRK-820 Development  (Oct 25, 2011)



 Recent  Drugs & OTC News   
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)

More Drugs & OTC news...

 Recent  Biotech News   
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)

More Biotech news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)